CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-25 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −1,667 | 15,000 | ||
| 2023-07-25 | DUGGAN ROBERT W Director | Option exercise | +1,667 | $5.95 | $10K | 36,231,624 |
| 2023-07-25 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −1,667 | 16,667 | ||
| 2023-07-12 | Danahy Kevin Patrick Chief Executive Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-07-12 | UECKER DARRIN Chief Technology Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-07-12 | Levinson Mitchell E. Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-07-07 | DUGGAN ROBERT W Director | Option exercise | +65,467 | $2.14 | $140K | 36,228,291 |
| 2023-07-07 | DUGGAN ROBERT W Director | Option exercise | +1,666 | $5.95 | $10K | 36,229,957 |
| 2023-07-07 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −65,467 | 0 | ||
| 2023-07-07 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −1,666 | 18,334 | ||
| 2023-07-05 | DUGGAN ROBERT W Director | Option exercise | +65,000 | $2.14 | $139K | 36,162,824 |
| 2023-07-05 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −65,000 | 65,467 | ||
| 2023-06-14 | DUGGAN ROBERT W Director | Option exercise | +5,683,163 | $2.05 | $11.7M | 36,097,824 |
| 2023-06-14 | DUGGAN ROBERT W Director | Option exercise | +81,025 | $2.05 | $166K | 492,069 |
| 2023-06-14 | DUGGAN ROBERT W Director | Option exercise · Warrant (right to buy) | −5,683,163 | 0 | ||
| 2023-06-14 | DUGGAN ROBERT W Director | Option exercise · Warrant (right to buy) | −81,025 | 0 | ||
| 2023-06-12 | UECKER DARRIN Chief Technology Officer | Option exercise | +7,365 | $2.05 | $15K | 148,941 |
| 2023-06-12 | UECKER DARRIN Chief Technology Officer | Option exercise · Warrant (right to buy) | −7,365 | 0 | ||
| 2023-06-12 | UECKER DARRIN Chief Technology Officer | Option exercise | +7,365 | $2.05 | $15K | 877,636 |
| 2023-06-12 | UECKER DARRIN Chief Technology Officer | Option exercise · Warrant (right to buy) | −7,365 | 0 |
Page 12 of 15 · 292 trades